Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Wipro Lt 559.50 3.82
Tata Stl 458.95 0.40
Tata Pow 88.00 0.28
Ong Corp 403.25 0.80
Hindalco 149.65 0.81
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Fresenius Kabi Oncology Limited
Fresenius Kabi Oncology Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:32545NSE:FKONCOBloomberg:FKOL@INReuters:FRES.BO
Market Lot: 1Face Value: 1ISIN Demat: INE575G01010
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
06-JUL-13 Fresenius Kabi Oncology announced on Friday that it has received a warning letter from US FDA, asking for certain other information and implementation of more corrective and preventive measures so as to avoid recurrence of deviations. 27-MAY-11 Fresenius Kabi Oncology today announced that the company to further leverage its R&D and manufacturing competencies by entering into contract R&D and manufacturing agreements with Fresenius K...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
  -
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Sep-2013(6)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 1625.104962.464711.19
Other Income8.5818.0113.86
Total Income1633.684980.474725.05
Cost of goods sold2434.164532.994568.61
OPBDIT-800.48447.48156.44
PAT-399.95805.89509.51
Gross Block---
Equity capital158.23158.23158.23
EPS (Rs.)-5.093.22
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-15.42 - 34.5825.36 - 51.24
Debt / Equity (x)---
Operating margin (% of OI)-49.0 9.0 3.3
Net margin (% of OI)-24.516.210.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
B - 310, Som Datt Chambers - I
Bhikaji Cama Place
New Delhi
Delhi-110 066
PHONE
(011) 2610 5570
FAX
(011) 2619 5965
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer